Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 54
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
AAPS PharmSciTech ; 25(5): 108, 2024 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-38730090

RESUMEN

Wound healing presents a complex physiological process that involves a sequence of events orchestrated by various cellular and molecular mechanisms. In recent years, there has been growing interest in leveraging nanomaterials and peptides to enhance wound healing outcomes. Nanocarriers offer unique properties such as high surface area-to-volume ratio, tunable physicochemical characteristics, and the ability to deliver therapeutic agents in a controlled manner. Similarly, peptides, with their diverse biological activities and low immunogenicity, hold great promise as therapeutics in wound healing applications. In this review, authors explore the potential of peptides as bioactive components in wound healing formulations, focusing on their antimicrobial, anti-inflammatory, and pro-regenerative properties. Despite the significant progress made in this field, several challenges remain, including the need for standardized characterization methods, optimization of biocompatibility and safety profiles, and translation from bench to bedside. Furthermore, developing multifunctional nanomaterial-peptide hybrid systems represents promising avenues for future research. Overall, the integration of nanomaterials made up of natural or synthetic polymers with peptide-based formulations holds tremendous therapeutic potential in advancing the field of wound healing and improving clinical outcomes for patients with acute and chronic wounds.


Asunto(s)
Portadores de Fármacos , Péptidos , Cicatrización de Heridas , Cicatrización de Heridas/efectos de los fármacos , Humanos , Péptidos/química , Péptidos/administración & dosificación , Péptidos/farmacología , Portadores de Fármacos/química , Animales , Sistemas de Liberación de Medicamentos/métodos , Nanoestructuras/química , Antiinflamatorios/farmacología , Antiinflamatorios/administración & dosificación , Antiinflamatorios/química , Nanopartículas/química , Antiinfecciosos/administración & dosificación , Antiinfecciosos/farmacología , Antiinfecciosos/química
2.
Biotechnol Appl Biochem ; 70(1): 51-67, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-35262954

RESUMEN

The present work involved development of phospholipid-based permeation enhancing nanovesicles (PENVs) for topical delivery of ketoprofen. Screening of phospholipids and process parameters was performed. Central composite design was used for optimization of factors, that is, amount (%, w/w) of phospholipid and ethanol at three levels. The optimized nanovesicles (NVs) were loaded with different terpenes and then incorporated into a gel base. Optimized NVs exhibited 69% entrapment efficiency, 51% transmittance, 328 nm mean vesicle size, and polydispersity index of 0.25. In vitro release kinetics evaluation indicated best fitting as per Korsemeyer-Peppa's model and drug release via Fickian-diffusion mechanism. The optimized NVs loaded with mint terpene showed minimal degree of deformability and maximal elasticity as compared with the conventional NVs and liposomes. Rheology and texture analysis indicated pseudoplastic flow and smooth texture of the vesicle gel formulation. Ex vivo permeation studies across Wistar rat skin indicated low penetration (0.43-fold decrease) and high skin retention (4.26-fold increase) of ketoprofen from the optimized PENVs gel vis-à-vis the conventional gel. Skin irritancy study indicated lower scores for PENVs gel construing its biocompatible nature. Stability studies confirmed cold storage is best suitable for vesicle gel, and optimized PENVs were found to be suitable for topical delivery of ketoprofen.


Asunto(s)
Cetoprofeno , Ratas , Animales , Cetoprofeno/metabolismo , Absorción Cutánea , Administración Cutánea , Fosfolípidos/metabolismo , Ratas Wistar , Sistemas de Liberación de Medicamentos , Piel , Liposomas/metabolismo , Portadores de Fármacos , Tamaño de la Partícula
3.
AAPS PharmSciTech ; 24(6): 155, 2023 Jul 20.
Artículo en Inglés | MEDLINE | ID: mdl-37468691

RESUMEN

The treatment of wounds is a serious problem all over the world and imposes a huge financial burden on each and every nation. For a long time, researchers have explored wound dressing that speeds up wound healing. Traditional wound dressing does not respond effectively to the wound-healing process as expected. Therapeutic active derived from plant extracts and extracted bioactive components have been employed in various regions of the globe since ancient times for the purpose of illness, prevention, and therapy. About 200 years ago, most medical treatments were based on herbal remedies. Especially in the West, the usage of herbal treatments began to wane in the 1960s as a result of the rise of allopathic medicine. In recent years, however, there has been a resurgence of interest in and demand for herbal medicines for a number of reasons, including claims about their efficacy, shifting consumer preferences toward natural medicines, high costs and negative side effects of modern medicines, and advancements in herbal medicines brought about by scientific research and technological innovation. The exploration of medicinal plants and their typical uses could potentially result in advanced pharmaceuticals that exhibit reduced adverse effects. This review aims to present an overview of the utilization of nanocarriers in plant-based therapeutics, including its current status, recent advancements, challenges, and future prospects. The objective is to equip researchers with a comprehensive understanding of the historical background, current state, and potential future developments in this emerging field. In light of this, the advantages of nanocarriers based delivery of natural wound healing treatments have been discussed, with a focus on nanofibers, nanoparticles, nano-emulsion, and nanogels.


Asunto(s)
Plantas Medicinales , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Cicatrización de Heridas
4.
AAPS PharmSciTech ; 24(5): 116, 2023 May 09.
Artículo en Inglés | MEDLINE | ID: mdl-37160772

RESUMEN

Three-dimensional (3D) printing technology has presently been explored widely in the field of pharmaceutical research to produce various conventional as well as novel dosage forms such as tablets, capsules, oral films, pellets, subcutaneous implants, scaffolds, and vaginal rings. The use of this innovative method is a good choice for its advanced technologies and the ability to make tailored medicine specifically for individual patient. There are many 3D printing systems that are used to print tablets, implants, and vaginal rings. Among the available systems, the fused deposition modeling (FDM) is widely utilized. The FDM has been regarded as the best choice of printer as it shows high potential in the production of tablets as a unit dose in 3D printing medicine manufacturing. In order to design a 3D-printed tablet or other dosage forms, the physicochemical properties of polymers play a vital role. One should have proper knowledge about the polymer's properties so that one can select appropriate polymers in order to design 3D-printed dosage form. This review highlighted the various physicochemical properties of polymers that are currently used as filaments in 3D printing. In this manuscript, the authors also discussed various systems that are currently adopted in the 3D printing.


Asunto(s)
Polímeros , Impresión Tridimensional , Femenino , Humanos , Comprimidos
5.
AAPS PharmSciTech ; 23(7): 244, 2022 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-36042060

RESUMEN

Foam is a dispersal of gas in solid foam or liquid foam. Solid foams are generally formed through quick curing of liquid foams. Because of their positive characteristics, simplicity of application, and improved patient acceptability/compliance, foams are an appealing and promising delivery strategy for medical, cosmetic, and pharmaceutical, applications. Recent breakthroughs in topical foams for cosmetic and dermal applications are described here, as well as categorization based on foam formulation and recent assessment techniques of critical physical properties of the topical foam. Despite the expanding amount of knowledge on topical foams for cutaneous applications, the majority of research has focused on the stability and structure of foam in contact with solid nonporous surfaces. It is still difficult to figure out how such foams destabilize when they come into touch with porous surfaces like skin or skin-like membranes. The foam-covered wide surface area and easily applied to the affected area. This type of delivery system also eliminates the chance of secondary infection that is associated with ointment and creams, which need to be applied to the affected area with help of fingers or an applicator.


Asunto(s)
Cosméticos , Sistemas de Liberación de Medicamentos , Aerosoles , Humanos , Piel
6.
Neurol Sci ; 42(5): 1785-1797, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-32885394

RESUMEN

The present investigation is focused on improving oral bioavailability of poorly soluble and lipophilic drugs, curcumin (CRM) and duloxetine (DXH), through the solid self-nanoemulsifying drug delivery system (S-SNEDDS) and identifying their potential against attenuation of NP in chronic constriction injury (CCI)-induced rats through the solid self-nanoemulsifying drug delivery system (S-SNEDDS). The optimized batch of S-SNEDDS reported was containing CRM and DXH (30 mg each), castor oil (20% w/w), tween-80 (40% w/w), transcutol-P (40% w/w), and syloid 244 FP (1 g). The high dose of each of naïve CRM (NCH), naïve DXH (NDH), physical mixture of DXH and CRM (C-NCM-DXH), S-SNEDDS-CRM (SCH), S-SNEDDS-DXH (SDH), and S-SNEDDS-CRM-DXH (C-SCH-SDH) was subjected for MTT assay. The developed formulations were subjected to pharmacokinetic studies and results showed about 8 to 11.06 and 2-fold improvement in oral bioavailability of CRM and DXH through S-SNEDDS. Furthermore, CCI-induced male Wistar rats were treated with SSNEDDS containing CRM and DXH, S-SNEDDS containing individual drug, individual naïve forms, and their combination from the day of surgery for 14 days and evaluated for behavioral at pre-determined time intervals. On the terminal day, animals were sacrificed to assess tissue myeloperoxidase, superoxide anion, protein, tumor necrosis factor-α, total calcium levels, and histopathological changes. Pronounced effect was observed in rats treated with S-SNEDDS containing both drugs with respect to rats receiving any of other treatments owing to enhanced oral bioavailability through S-SNEDDS. Therefore, it can be concluded that S-SNEDDS of both drugs and their coadministration can accelerate the prevention of NP.


Asunto(s)
Curcumina , Neuralgia , Administración Oral , Animales , Sistemas de Liberación de Medicamentos , Clorhidrato de Duloxetina , Emulsiones , Masculino , Neuralgia/tratamiento farmacológico , Tamaño de la Partícula , Ratas , Ratas Wistar , Solubilidad
7.
Andrologia ; 51(1): e13153, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30251379

RESUMEN

Bioresorbable vascular scaffolds (BVS) have been designed to overcome long-term limitations of metallic drug-eluting stents including permanent metallic "caging" that might trigger late coronary adverse events. Here, we report for the first time a case of 72-year gentleman with previous coronary artery disease, treated by successful implantation of BVS (Absorb, Abbott Vascular) due to significant stenosis of internal pudenda artery and erectile dysfunction. After 2 years, BVS completely resorbed and there were no signs of pudendal artery restenosis on CT scan, whereas blood flow and sexual function improved.


Asunto(s)
Implantes Absorbibles , Disfunción Eréctil/cirugía , Pene/cirugía , Anciano , Constricción Patológica/cirugía , Humanos , Masculino , Pene/irrigación sanguínea , Resultado del Tratamiento
9.
AAPS PharmSciTech ; 18(1): 58-71, 2017 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-26868380

RESUMEN

Piroxicam is used in the treatment of rheumatoid arthritis, osteoarthritis, and other inflammatory diseases. Upon oral administration, it is reported to cause ulcerative colitis, gastrointestinal irritation, edema and peptic ulcer. Hence, an alternative delivery system has been designed in the form of transethosome. The present study describes the preparation, optimization, characterization, and ex vivo study of piroxicam-loaded transethosomal gel using the central composite design. On the basis of the prescreening study, the concentration of lipids and ethanol was kept in the range of 2-4% w/v and 0-40% v/v, respectively. Formulation was optimized by measuring drug retention in the skin, drug permeation, entrapment efficiency, and vesicle size. Optimized formulation was incorporated in hydrogel and compared with other analogous vesicular (liposomes, ethosomes, and transfersomes) gels for the aforementioned responses. Among the various lipids used, soya phosphatidylcholine (SPL 70) and ethanol in various percentages were found to affect drug retention in the skin, drug permeation, vesicle size, and entrapment efficiency. The optimized batch of transethosome has shown 392.730 µg cm-2 drug retention in the skin, 44.312 µg cm-2 h-1 drug permeation, 68.434% entrapment efficiency, and 655.369 nm vesicle size, respectively. It was observed that the developed transethosomes were found superior in all the responses as compared to other vesicular formulations with improved stability and highest elasticity. Similar observations were noted with its gel formulation.


Asunto(s)
Hidrogel de Polietilenoglicol-Dimetacrilato/química , Piroxicam/química , Piel/metabolismo , Administración Cutánea , Animales , Química Farmacéutica/métodos , Portadores de Fármacos/química , Sistemas de Liberación de Medicamentos/métodos , Hidrogel de Polietilenoglicol-Dimetacrilato/administración & dosificación , Liposomas/administración & dosificación , Liposomas/química , Tamaño de la Partícula , Permeabilidad , Piroxicam/administración & dosificación , Absorción Cutánea , Porcinos
10.
Opt Express ; 22(25): 30899-909, 2014 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-25607039

RESUMEN

We present a novel method for distortion elimination in phase-modulated analog optical links. A small part of the phase modulated signal seeds a four-wave mixing comb source, which generates lightwaves with integer multiples of the phase modulation of the original signal. These lightwaves are scaled and re-combined with the original phase-modulated signal to cancel the distortion generated in the interferometric phase-to-amplitude conversion process. Experimentally, we demonstrate full cancelation of the third-order distortion of the receiver and achieve a 19-dB improvement in the link's SFDR at a 1-Hz bandwidth. This approach is readily extendable to eliminate all relevant higher-order distortion products or synthesize arbitrary phase-to-amplitude transfer functions.

11.
Pharm Dev Technol ; 19(2): 160-3, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23369039

RESUMEN

OBJECTIVE: Tamoxifen (TAM) is widely employed in the treatment of breast malignancies and is also found to be effective in psoriasis treatment. The current studies aimed to explore the antipsoriatic potential of topical TAM encapsulated in the new generation phospholipid-based vesicular and micellar systems, i.e. flexible membrane vesicles (FMVs) and pluronic lecithinized organogels (PLOs). METHODS: TAM-loaded-FMVs were prepared by thin-film hydration technique, while TAM-PLOs were prepared by simple mixing. Mouse-tail model was used to evaluate the antipsoriatic activity of the novel formulations. The mouse tails were treated once-a-day with different formulations for a period of four weeks and prepared for longitudinal histological sections by hematoxylin-eosin staining technique. The length of the orthokeratotic regions in stratum granulosum was measured on 10 sequential scales per tail section as percentage of the full length of the scale, and the drug activity was calculated further. RESULTS: Evaluation of antipsoriatic activity on mice tail revealed significantly higher (p < 0.01) efficacy of TAM-FMV gel (i.e. 35.8%) and TAM-PLO (i.e. 24.6%) vis-à-vis the conventional TAM-hydrogel (i.e. 10.2%). CONCLUSIONS: The results of these studies demonstrated immense potential of the topically applied TAM-encapsulated vesicular and micellar systems in psoriasis, thus calling for more comprehensive investigations to establish the role of TAM in the management of psoriasis.


Asunto(s)
Antineoplásicos Hormonales/administración & dosificación , Liposomas/química , Micelas , Fosfolípidos/química , Psoriasis/tratamiento farmacológico , Tamoxifeno/administración & dosificación , Administración Tópica , Animales , Antineoplásicos Hormonales/uso terapéutico , Modelos Animales de Enfermedad , Femenino , Geles/química , Geles/metabolismo , Lecitinas/química , Lecitinas/metabolismo , Liposomas/metabolismo , Ratones , Fosfolípidos/metabolismo , Psoriasis/patología , Piel/efectos de los fármacos , Piel/patología , Tamoxifeno/uso terapéutico
12.
Int J Biol Macromol ; 267(Pt 2): 131335, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38604431

RESUMEN

Nanoparticles (NPs) have been extensively investigated for their potential in nanomedicine. There is a significant level of enthusiasm about the potential of NPs to bring out a transformative impact on modern healthcare. NPs can serve as effective wound dressings or delivery vehicles due to their antibacterial and pro-wound-healing properties. Biopolymer-based NPs can be manufactured using various food-grade biopolymers, such as proteins, polysaccharides, and synthetic polymers, each offering distinct properties suitable for different applications which include collagen, polycaprolactone, chitosan, alginate, and polylactic acid, etc. Their biodegradable and biocompatible nature renders them ideal nanomaterials for applications in wound healing. Additionally, the nanofibers containing biopolymer-based NPs have shown excellent anti-bacterial and wound healing activity like silver NPs. These NPs represent a paradigm shift in wound healing therapies, offering targeted and personalized solutions for enhanced tissue regeneration and accelerated wound closure. The current review focuses on biopolymer NPs with their applications in wound healing.


Asunto(s)
Nanopartículas , Cicatrización de Heridas , Humanos , Antibacterianos/química , Antibacterianos/farmacología , Vendajes , Materiales Biocompatibles/química , Materiales Biocompatibles/farmacología , Biopolímeros/química , Biopolímeros/uso terapéutico , Biopolímeros/farmacología , Quitosano/química , Nanopartículas/química , Cicatrización de Heridas/efectos de los fármacos
13.
Curr Pharm Des ; 30(6): 410-419, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38747045

RESUMEN

Foam-based delivery systems contain one or more active ingredients and dispersed solid or liquid components that transform into gaseous form when the valve is actuated. Foams are an attractive and effective delivery approach for medical, cosmetic, and pharmaceutical uses. The foams-based delivery systems are gaining attention due to ease of application as they allow direct application onto the affected area of skin without using any applicator or finger, hence increasing the compliance and satisfaction of the patients. In order to develop foam-based delivery systems with desired qualities, it is vital to understand which type of material and process parameters impact the quality features of foams and which methodologies may be utilized to investigate foams. For this purpose, Quality-by-Design (QbD) approach is used. It aids in achieving quality-based development during the development process by employing the QbD concept. The critical material attributes (CMAs) and critical process parameters (CPPs) were discovered through the first risk assessment to ensure the requisite critical quality attributes (CQAs). During the initial risk assessment, the high-risk CQAs were identified, which affect the foam characteristics. In this review, the authors discussed the various CMAs, CPPs, CQAs, and risk factors associated in order to develop an ideal foam-based formulation with desired characteristics.


Asunto(s)
Sistemas de Liberación de Medicamentos , Humanos , Composición de Medicamentos , Diseño de Fármacos , Preparaciones Farmacéuticas/química , Preparaciones Farmacéuticas/administración & dosificación , Química Farmacéutica
14.
Curr Pharm Des ; 30(19): 1490-1506, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38644722

RESUMEN

Orthodontic pain is characterized by sensations of tingling, tooth discomfort, and intolerance. According to the oral health report, over forty percent of children and adolescents have undergone orthodontic treatment. The efficacy of orthodontic treatment involving braces can be compromised by the diverse levels of discomfort and suffering experienced by patients, leading to suboptimal treatment outcomes and reduced patient adherence. Nanotechnology has entered all areas of science and technology. This review provides an overview of nanoscience, its application in orthodontics, the underlying processes of orthodontic pain, effective treatment options, and a summary of recent research in Nano-dentistry. The uses of this technology in healthcare span a wide range, including enhanced diagnostics, biosensors, and targeted drug delivery. The reason for this is that nanomaterials possess distinct qualities that depend on their size, which can greatly enhance human well-being and contribute to better health when effectively utilized. The field of dentistry has also experienced significant advancements, particularly in the past decade, especially in the utilization of nanomaterials and technology. Over time, there has been an increase in the availability of dental nanomaterials, and a diverse array of these materials have been extensively studied for both commercial and therapeutic purposes.


Asunto(s)
Sistemas de Liberación de Medicamentos , Nanoestructuras , Ortodoncia , Dolor , Ortodoncia/instrumentación , Ortodoncia/métodos , Ortodoncia/tendencias , Dolor/tratamiento farmacológico , Dolor/etiología , Dolor/patología , Nanoestructuras/química , Nanoestructuras/uso terapéutico , Sistemas de Liberación de Medicamentos/tendencias , Humanos , Aparatos Ortodóncicos/efectos adversos , Manejo del Dolor/tendencias , Analgésicos/química , Analgésicos/uso terapéutico
15.
Curr Pharm Des ; 30(22): 1725-1745, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38847167

RESUMEN

Diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels and encompasses various types like type 1, type 2, gestational, and prediabetes. This review delves into the intricacies of type-2 diabetes mellitus and its ideal management. Presently, a spectrum of herbal and synthetic drugs is employed for type-2 diabetes mellitus management. We gathered information about diabetes mellitus from articles published up to 2024 and listed in PubMed, Web of Science, Elsevier, Google Scholar, and similar databases. The keywords used in our search included "diabetes", "herbal drugs", "nano-carriers", "transdermal drug delivery", etc. By carefully analyzing the research on type-2 diabetes-mellitus, it was found that there is an increase in diabetes-based research, which can be demonstrated by contemplating the PubMed search engine results using transdermal delivery for type-2 diabetes-mellitus as a keyword. The oral consumption of these drugs is associated with numerous side effects, including obesity, pancreatic cancer, and hormonal imbalances. To surmount these challenges, the utilization of nano-carriers and transdermal drug delivery systems emerges as a promising avenue aiming to enhance the therapeutic efficacy of drugs. Nano-carriers represent a revolutionary approach, integrating cutting-edge technologies, inventive strategies, and methodologies to deliver active molecules in concentrations that are both safe and effective, thereby eliciting the desired pharmacological response. This review critically examines the constraints associated with traditional oral administration of anti-diabetic drugs and underscores the manifold initiatives undertaken to revolutionize drug delivery. This review focuses on the limitations associated with the conventional oral administration of anti-diabetic drugs and the many initiatives made so far for the effective and safe delivery of drugs using innovative constituents and techniques.


Asunto(s)
Administración Cutánea , Diabetes Mellitus Tipo 2 , Sistemas de Liberación de Medicamentos , Hipoglucemiantes , Humanos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hipoglucemiantes/administración & dosificación , Portadores de Fármacos/química , Animales , Nanopartículas/administración & dosificación
16.
J Pharm Sci ; 113(9): 2795-2807, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38992795

RESUMEN

Burn injuries worldwide pose significant health risks due to frequent microbial infections, which worsen complications and increase mortality rates. The conventional antimicrobial formulations are available in the form of ointments and creams. These formulations are very greasy and stick to the clothes. The applications of these formulations by finger or applicator produce pain in the affected area and incur the possibility of microbial infection. To overcome these hurdles, authors developed a novel non-propellent foam (NPF) based formulation containing chlorhexidine for effective topical delivery. Initially, NPF containing Labrasol® (26.7%), sodium lauryl sulfate (1.2%), hydroxy propyl methyl cellulose (0.56%), butylated hydroxytoluene (0.1%), ethanol (1%), and distilled water was prepared and assessed for its consistency, and ability to form foam. The NPF was statistically optimized using the Box-Behnken design to determine the effect of polymer and surfactants on the critical foam properties. The optimized formulation showed a collapse time of 45 s with a unique nature of collapsing upon slight touch which is highly beneficial for burn patients with microbial infection. The diffusion study showed that more than 90% of the drug was released within 6 h. The skin permeation study showed that 23% of the total drug permeated through the skin after 6 h with 7.64 µg/cm2/h permeation flux. The developed formulation showed good antibacterial activity. The minimum inhibitory concentration of prepared NPF was found to be 2.5 µg/mL, 2.5 µg/mL, and 5.0 µg/mL against E. coli (MTCC-1687), P. aeruginosa (MTCC-1688), and S aureus (MTCC-737) respectively. The developed NPF formulation showed quick collapse time, excellent spreadability, good anti-bacterial activity, and a non-sticky nature representing a promising avenue for burn wound treatment without using any applicator.


Asunto(s)
Quemaduras , Quemaduras/tratamiento farmacológico , Animales , Clorhexidina/administración & dosificación , Clorhexidina/química , Química Farmacéutica/métodos , Antiinfecciosos Locales/administración & dosificación , Antiinfecciosos Locales/farmacología , Antiinfecciosos Locales/química , Pruebas de Sensibilidad Microbiana , Composición de Medicamentos/métodos , Piel/metabolismo , Piel/efectos de los fármacos , Piel/microbiología , Staphylococcus aureus/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Tensoactivos/química , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Antibacterianos/química , Pseudomonas aeruginosa/efectos de los fármacos , Administración Cutánea , Humanos
17.
Ann Biomed Eng ; 52(5): 1184-1194, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38418691

RESUMEN

The emergence of bone tissue engineering as a trend in regenerative medicine is forcing scientists to create highly functional materials and scaffold construction techniques. Bone tissue engineering uses 3D bio-printed scaffolds that allow and stimulate the attachment and proliferation of osteoinductive cells on their surfaces. Bone grafting is necessary to expedite the patient's condition because the natural healing process of bones is slow. Fused deposition modeling (FDM) is therefore suggested as a technique for the production process due to its simplicity, ability to create intricate components and movable forms, and low running costs. 3D-printed scaffolds can repair bone defects in vivo and in vitro. For 3D printing, various materials including metals, polymers, and ceramics are often employed but polymeric biofilaments are promising candidates for replacing non-biodegradable materials due to their adaptability and environment friendliness. This review paper majorly focuses on the fused deposition modeling approach for the fabrication of 3D scaffolds. In addition, it also provides information on biofilaments used in FDM 3D printing, applications, and commercial aspects of scaffolds in bone tissue engineering.


Asunto(s)
Ingeniería de Tejidos , Andamios del Tejido , Humanos , Ingeniería de Tejidos/métodos , Huesos , Polímeros , Impresión Tridimensional
18.
J Biomol Struct Dyn ; : 1-15, 2024 Mar 03.
Artículo en Inglés | MEDLINE | ID: mdl-38433407

RESUMEN

Current investigation deals with the gel formulation of purified polyphenol loaded nanoparticles for enhanced wound healing. Polyphenols purified using column chromatography an were characterized using HPLC in fractions. Silver nanoparticles were characterization using SEM, AFM, TEM, DLS. Cytotoxic effect was checked on L929 (Mouse fibroblast cells). Bioactive loaded nanoparticles were formulated in gel and subjected for physical characterization. Excision wound wistar rat models were established to measure the wound contraction measurement, histopathological studies, and biochemical assays. Docking and Simulation studies were performed to check the binding and stability with receptors progressing the chronic wound. From the column chromatography, B fraction has shown the presence of maximum polyphenolic content and as well as the polyphenol compounds such as quercetin, rutin and tannic acid as confirmed by the HPLC. Synthesize B fraction-AgNP were found to be below 100 nm in size and spherical in shape as per the characterization. No cytotoxic effect was observed on L929 cells treated with B fraction and its nanoparticles. Formulated B fraction-AgNP gel has revealed the better stability and earlier wound contraction, i.e. before the completion of 14 days of topical treatment. Histopathology studies and collagen content has confirmed the re-epithelization in skin wounds. MD simulation revealed the stability with PI3K and AKT. This can be concluded that tobacco stem polyphenol loaded nanoparticles has potent wound healing activity that can be utilized as nano-drug delivery system for suppression of chronic wound development.Communicated by Ramaswamy H. Sarma.

19.
Ther Deliv ; 15(11): 893-910, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39268925

RESUMEN

Acute myeloid leukemia (AML), a heterogeneous hematopoietic cancer prevalent in adults, has been a leading cause of leukemia-associated deaths for decades. Despite advancements in understanding its pathology and pharmacological targets, therapeutic strategies have seen minimal change. The standard treatment, combining cytarabine and anthracycline, has persisted, accompanied by challenges such as pharmacokinetic issues and non-specific drug delivery, leading to severe side effects. Nanotechnology offers a promising solution through combination drug delivery. FDA-approved CPX351 (VYXEOS™) a liposomal formulation delivering doxorubicin and cytarabine, exemplifies enhanced therapeutic efficacy. Ongoing research explores various nanocarriers for delivering multiple bioactives, addressing drug targeting, pharmacokinetics and chemoresistance. This review highlights nanotechnology-based combination therapies for the effective management of AML, presenting a potential breakthrough in leukemia.


[Box: see text].


Asunto(s)
Citarabina , Doxorrubicina , Leucemia Mieloide Aguda , Humanos , Leucemia Mieloide Aguda/tratamiento farmacológico , Citarabina/administración & dosificación , Doxorrubicina/administración & dosificación , Liposomas , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Sistemas de Liberación de Medicamentos/métodos , Animales , Nanotecnología/métodos , Portadores de Fármacos/química , Nanopartículas , Sistema de Administración de Fármacos con Nanopartículas/química , Daunorrubicina
20.
Artículo en Inglés | MEDLINE | ID: mdl-39136915

RESUMEN

Sustainable agriculture and the provision of food for all become dependent on the availability of efficient diagnostic techniques for the prompt identification of plant diseases. Current scientific findings suggest that nanotechnology can positively affect the agrifood industry by reducing the adverse effects of agricultural practices on human health and the environment, increasing food security and productivity, and fostering social and economic justice. Nanomaterials' unique physical and chemical characteristics have made it possible to employ them as cutting-edge, effective diagnostic instruments for various plant infections and other significant disease biomarkers. By creating diagnostic instruments and methods, nanobiosensors significantly contribute to the revolution of farming. In real time, nanobiosensors can detect infections, metabolites, pesticides, nutrient levels, soil moisture, and temperature. This helps with precision farming techniques and maximises resource use. To better address agricultural concerns, we have included the most recent research on the concept, types, applications, commercial aspects, and future scope of nanobiosensors in this review.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA